Sensus Healthcare (SRTS) Stock: Buy, Sell, or Hold?
SRTS - Sensus Healthcare, Inc
$3.19
-0.07 (-2.15%)
âŧ
5d:
-9.38%
30d:
+7.05%
90d:
+18.15%
WAIT
LOW Confidence
Analysis Updated: Sep 4, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When SRTS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SRTS is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SRTS is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SRTS is currently trading at $3.19, which is considered fair relative to its 30-day fair value range of $2.95 to $3.35. From a valuation perspective, the stock is trading at a discount (Forward PE: -18.4) compared to its historical average (204.1). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SRTS is in a downtrend. Immediate support is located at $3.09, while resistance sits at $3.72.
Market Sentiment: SRTS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.38 (+68.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SRTS is in a downtrend. Immediate support is located at $3.09, while resistance sits at $3.72.
Market Sentiment: SRTS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.38 (+68.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.95 -
$3.35
Company Quality Score
39/100
(SELL)
Options IV Signal
31th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
57.7%
Protect Your Profits
Holding SRTS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 31th percentile)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 68.5% below Wall St target ($5.38)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 39/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.95 -
$3.35
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$0.49
(15.3%)
Support & Resistance Levels
Support Level
$3.09
Resistance Level
$3.72
Current Trend
Downtrend
Technical data as of
Sep 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-18.41
Wall Street Target
$5.38
(+68.5%)
Revenue Growth (YoY)
-68.7%
Earnings Growth (YoY)
433.3%
Profit Margin
-88.4%
PE vs Historical
-18.4 vs 204.1
CHEAP
Share & Embed Analysis
Last updated: September 07, 2026 6:10 AM ET
Data refreshes hourly during market hours. Next update: 7:10 AM
Data refreshes hourly during market hours. Next update: 7:10 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 46 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 50 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 49 HOLD |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$83 | 48 HOLD |
Advanced SRTS Option Strategies
Professional options setups generated by AI based on today's SRTS price and gamma walls.
